Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients.

Orally administered by statin-intolerant patients, bempedoic acid is a novel drug used to treat high LDL cholesterol conditions indicative of cardiovascular disease.

• Government to Introduce New Policy for Elderly Soon
• CleanMax and Equinix Partnered Up To Build 33 MW Projects 
• NTPC and ONGC Joint Venture Arms Declared Highest for Ayana Renewable 
• US Markets Slips as Investors Book Profit 
• Boat Gears Up for $300-500 Million IPO

“An estimated 112 million Indian adults have high LDL cholesterol levels, and large numbers of dyslipidemia patients receiving statin therapy continue to experience uncontrolled dyslipidemia for these patients, bebedoic acid is a silver lining,” Director Sandeep Jain said.